Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 25, 2025Open Access

A Decade of Advances in Lung Cancer: Progress, Artificial Intelligence, and Global Collaboration

View Full Paper
Ask AI
Bookmark
Share

Authors

ANA.A.A. Nasser

Discussion

Loading...

Member takes

Overview

This review highlights progress in lung cancer outcomes and AI's role in treatment strategies through global collaboration.

Key Points

  • Lung cancer remains a top cause of cancer mortality, but recent advances have improved detection and treatment outcomes.
  • Early detection methods like low-dose CT screening have significantly reduced mortality in high-risk populations.
  • Innovative treatments such as targeted therapies and immunotherapy show promise in improving patient care.
  • Ongoing global collaboration is essential for addressing challenges like drug resistance and disparities in treatment access.

Cite This Study

A.A.A. Nasser (2025) studied this question.

synapsesocial.com/papers/689a0933e6551bb0af8ce34fhttps://doi.org/10.20944/preprints202507.1763.v1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Impact of Artificial Intelligence on Lung Cancer Diagnosis and Personalized Treatment2025
  2. 2Immune mechanisms and therapeutic advances in lung cancer: A comprehensive review2025
  3. 3Applications and future prospects of artificial intelligence in the diagnosis and prognosis of lung cancer2025
  4. 4AI-Based Computational Pathology for Precision Lung Cancer Management: A Systematic Review and Meta-Analysis of Diagnostics and Prognostic Algorithms2025
  5. 5Comprehensive Advances in Non-Small Cell Lung Cancer: From Molecular Mechanisms to Precision Therapy2025